NuGen Announces Publication of Q2 2024 Financial Results and Update on Proposed Private Placement Page 1

Toronto, Ontario–(Newsfile Corp. – August 29, 2024) – NuGen Medical Devices Inc. (TSXV:NGMD) (the “Company” or “NuGen“) a leading developer of needle-free devices for the subcutaneous delivery of therapeutic agents, announces the publication of its financial results for the second quarter of 2024 and is pleased to provide updates on its commercial progress and the proposed private placement of up to $10 million of secured convertible notes (the “To offer“).

Q2 financial statements reflect continued commercial scale-up